医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Molex Dongguan China Achieves FDA Registration for Class I Medical Devices

2014年08月19日 PM10:07
このエントリーをはてなブックマークに追加


 

LISLE, Ill.

Molex Incorporated, a global manufacturer of electronic solutions, announced today that the Molex Dongguan, China facility is now registered with the U.S. Food and Drug Administration (FDA) as a compliant manufacturer of Class I medical devices. Manufacturers involved in the production and distribution of medical devices intended for use in the U.S. must register annually with the FDA regulatory agency, which is under the auspices of the U.S. Department of Health and Human Services.

“As a trusted partner providing integrated solutions for disposable patient sensors and other medical products, we are pleased to give Molex customers the added assurance of U.S. FDA registration,” states Justin Spitzer, business development manager, Molex. “Molex Dongguan adheres to stringent quality systems that ensure our products meet or exceed FDA Class I standards and requirements for medical devices used in the care of patients.”

Part of an ongoing process improvement plan by the Molex printed circuit products group, U.S. FDA registration confirms the Dongguan China site’s adherence with FDA inspections, tracking and traceability criteria. Molex Dongguan and other Molex manufacturing facilities maintain certification in ISO 9001 quality management and ISO 14001 environmental management.

“Molex enables medical device designs that drive healthcare innovation. Patient monitors are evolving from bedside equipment to smaller, lightweight, integrated solutions. As high volume markets expand for portable and wearable patient monitors requiring quality disposable sensors, we are pleased to provide medical device manufacturers the quality FDA registered products they need at a competitive price point,” adds Spitzer.

In addition to disposable sensor technologies, the Molex printed circuit products group provides flexible print circuits, printed circuit boards, assemblies, membrane switches, user interfaces and capacitive touch technologies. For information about Molex U.S. medical solutions, please visit www.molex.com/industry/medical.html.

About Molex Incorporated

Providing more than connectors, Molex delivers complete interconnect solutions for a number of markets including: data communications, telecommunications, scientific, consumer electronics, industrial, automotive, commercial vehicle, aerospace and defense, medical and lighting. Established in 1938, the company operates 45 manufacturing locations in 17 countries. The Molex website is www.molex.com. Follow us at www.twitter.com/molexconnectors, watch our videos at www.youtube.com/molexconnectors, connect with us at www.facebook.com/molexconnectors and read our blog at www.connector.com.

Molex is a registered trademark of Molex Incorporated

CONTACT

FOR EDITORIAL INFORMATION
Outlook Marketing Services
Christa
Carroll
Senior Vice President
630.408.9164
Christa.Carroll@molex.com
or
Molex
Incorporated
Carol Magosky
Americas Marketing Communications
Manager
630.718.5290
Carol.Magosky@molex.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
  • Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
  • ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu neuartigem Antikörper-Wirkstoff-Konjugat ADCT-402